DK1960515T3 - Inflammationshæmmende peptider - Google Patents

Inflammationshæmmende peptider

Info

Publication number
DK1960515T3
DK1960515T3 DK06820396.7T DK06820396T DK1960515T3 DK 1960515 T3 DK1960515 T3 DK 1960515T3 DK 06820396 T DK06820396 T DK 06820396T DK 1960515 T3 DK1960515 T3 DK 1960515T3
Authority
DK
Denmark
Prior art keywords
peptide
seq
present
inflammation
acid sequence
Prior art date
Application number
DK06820396.7T
Other languages
English (en)
Inventor
Marie Cumberbatch
Rebecca Jane Dearman
Ian Kimber
Russell Viner
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of DK1960515T3 publication Critical patent/DK1960515T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK06820396.7T 2005-12-06 2006-12-04 Inflammationshæmmende peptider DK1960515T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0524884.4A GB0524884D0 (en) 2005-12-06 2005-12-06 Improvements in or relating to organic compounds
PCT/GB2006/004510 WO2007066081A1 (en) 2005-12-06 2006-12-04 Anti-inflammatory peptides

Publications (1)

Publication Number Publication Date
DK1960515T3 true DK1960515T3 (da) 2011-09-05

Family

ID=35686177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06820396.7T DK1960515T3 (da) 2005-12-06 2006-12-04 Inflammationshæmmende peptider

Country Status (9)

Country Link
US (1) US8188053B2 (da)
EP (1) EP1960515B1 (da)
JP (1) JP5280855B2 (da)
CN (1) CN101384709B (da)
AT (1) ATE510008T1 (da)
DK (1) DK1960515T3 (da)
ES (1) ES2366715T3 (da)
GB (1) GB0524884D0 (da)
WO (1) WO2007066081A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524884D0 (en) 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds
KR102026800B1 (ko) * 2012-11-13 2019-09-30 (주)아모레퍼시픽 티오레독신을 함유하는 피부 외용제 조성물
CN114533850A (zh) * 2017-07-05 2022-05-27 江阴贝瑞森制药有限公司 肽的抗炎用途
US11364321B2 (en) 2017-10-11 2022-06-21 Arizona Board Of Regents On Behalf Of Arizona State University Nano scale decoration of scaffold-free microtissue using functionalised gold nanostructures
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501067D0 (sv) * 1995-03-24 1995-03-24 Astra Ab New peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
AU3239400A (en) * 1999-02-22 2000-09-04 University Of Iowa Research Foundation, The Method for inhibiting inflammatory responses
AU2002232819B2 (en) * 2000-12-19 2008-01-03 Sembiosys Genetics Inc. Methods for the production of multimeric proteins, and related compositions
JP4273234B2 (ja) * 2003-03-31 2009-06-03 独立行政法人産業技術総合研究所 チオレドキシン改変体
US7183381B2 (en) * 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
GB0524884D0 (en) 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
US8188053B2 (en) 2012-05-29
CN101384709A (zh) 2009-03-11
ES2366715T3 (es) 2011-10-24
EP1960515A1 (en) 2008-08-27
EP1960515B1 (en) 2011-05-18
JP2009518370A (ja) 2009-05-07
ATE510008T1 (de) 2011-06-15
GB0524884D0 (en) 2006-01-11
US20090253631A1 (en) 2009-10-08
WO2007066081A1 (en) 2007-06-14
JP5280855B2 (ja) 2013-09-04
CN101384709B (zh) 2012-01-04

Similar Documents

Publication Publication Date Title
JP5002603B2 (ja) 新規なペプチド及びこれの用途
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
ATE462000T1 (de) Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin
NZ601868A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
ATE417595T1 (de) Keratin-bindende polypeptide
RS53505B1 (en) OXYTOMODULIN PEPTIDE ANALOG
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
MX340014B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
NZ562436A (en) Toll-like receptor 14 (TLR14) and use thereof
DK1960515T3 (da) Inflammationshæmmende peptider
NZ596043A (en) Allergy inhibitor compositions and kits and methods of using the same
ATE355297T1 (de) Tgf-beta inhibitoren und methoden
TW201710287A (zh) 蛋白酶抗性之脂化肽
DE60226323D1 (de) Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen
NO20081453L (no) Sammensetninger og fremgangsmater for diagnostisering og behandling av inflammasjon
NZ591133A (en) Novel melanoma antigen peptide and uses thereof
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
NZ591825A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
DE602007010969D1 (de) Zytokinderivate
Yang et al. Effects of collagen hydrolysates on UV-induced photoaging mice: Gly-Pro-Hyp as a potent anti-photoaging peptide
WO2018031730A3 (en) Peptide inhibitors of phosphoglycerate mutase and methods of use
ATE417061T1 (de) Scorpionpeptid als blutdrucksenkendes mittel
GB201211586D0 (en) Japanese cedar peptides for preventing or treating allergy